Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/14/25
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 10/25/24
End: 02/04/29
Due: 02/04/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. | NCT07024407 | Ashibio Inc | user2@example.com | None | 2025-05-14 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) | NCT06508021 | Ashibio Inc | user2@example.com | None | 2024-10-25 | 2029-02-04 | 2030-02-04 | - | - | 2025-07-14 |